Library

BCM-95® (CURCUGREEN®), 22 Feb 2015
Published on : BMC Cancer . 2015 Apr 10;15:250. doi: 10.1186/s12885-015-1291-0.

Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer

Mehdi Shakibaei , Patricia Kraehe Bastian Popper, Parviz Shayan , Ajay Goel , Constanze Buhrmann

PMID: 25884903 PMCID: PMC4406109 DOI: 10.1186/s12885-015-1291-0

Background: To overcome the limitations of animal-based experiments, 3D culture models mimicking the tumor microenvironment in vivo are gaining attention. Herein, we investigated an alginate-based 3D scaffold for screening of 5-fluorouracil (5-FU) or/and curcumin on malignancy of colorectal cancer cells (CRC).

Methods: The potentiation effects of curcumin on 5-FU against proliferation and metastasis of HCT116 cell and its corresponding isogenic 5-FU-chemoresistant cells (HCT116R) were examined in a 3D-alginate tumor model.

Results: CRC cells encapsulated in alginate were able to proliferate in 3D-colonospheres in a vivo-like phenotype and invaded from alginate. During cultivation of cells in alginate, we could isolate 3 stages of cells, (1) alginate proliferating (2) invasive and (3) adherent cells. Tumor-promoting factors (CXCR4, MMP-9, NF-κB) were significantly increased in the proliferating and invasive compared to the adherent cells, however HCT116R cells overexpressed factors in comparison to the parental HCT116, suggesting an increase in malignancy behavior. In alginate, curcumin potentiated 5-FU-induced decreased capacity for proliferation, invasion and increased more sensitivity to 5-FU of HCT116R compared to the HCT116 cells. IC50 for HCT116 to 5-FU was 8nM, but co-treatment with 5 μM curcumin significantly reduced 5-FU concentrations in HCT116 and HCT116R cells (0.8nM, 0.1nM, respectively) and these effects were accompanied by down-regulation of NF-κB activation and NF-κB-regulated gene products.

Conclusions: Our results demonstrate that the alginate provides an excellent tumor microenvironment and indicate that curcumin potentiates and chemosensitizes HCT116R cells to 5-FU-based chemotherapy that may be useful for the treatment of CRC and to overcome drug resistance.

https://pubmed.ncbi.nlm.nih.gov/25884903/


Keywords

  • bcm
  • biocurcumax
  • clinical study
  • colorectal cancer
  • curcugreen
  • Curcumin
  • research
  • tumor
  • turmeric
  • turmeric extract

References

References

    1. Smalley KS, Lioni M, Herlyn M. Life isn’t flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim. 2006;42(8–9):242–7. doi: 10.1290/0604027.1. – DOI – PubMed
    1. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci U S A. 1992;89(19):9064–8. doi: 10.1073/pnas.89.19.9064. – DOI – PMC – PubMed
    1. Kievit FM, Florczyk SJ, Leung MC, Veiseh O, Park JO, Disis ML, et al. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials. 2010;31(22):5903–10. doi: 10.1016/j.biomaterials.2010.03.062. – DOI – PMC – PubMed
    1. Shakibaei M, De Souza P. Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads. Cell Biol Int. 1997;21(2):75–86. doi: 10.1006/cbir.1996.0119. – DOI – PubMed
    1. Tang C, Ang BT, Pervaiz S. Cancer stem cell: target for anti-cancer therapy. FASEB J. 2007;21(14):3777–85. doi: 10.1096/fj.07-8560rev. – DOI – PubMed
    1. Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC. Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. PLoS One. 2013;8(9) doi: 10.1371/journal.pone.0075187. – DOI – PMC – PubMed
    1. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653–64. doi: 10.1038/nrclinonc.2010.139. – DOI – PMC – PubMed
    1. Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8(10):839–45. doi: 10.1038/nrm2236. – DOI – PubMed
    1. Oshikata A, Matsushita T, Ueoka R. Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. J Biosci Bioeng. 2011;111(5):590–3. doi: 10.1016/j.jbiosc.2011.01.006. – DOI – PubMed
    1. Godugu C, Patel AR, Desai U, Andey T, Sams A, Singh M. AlgiMatrix based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One. 2013;8(1) doi: 10.1371/journal.pone.0053708. – DOI – PMC – PubMed
    1. Ong SM, Zhao Z, Arooz T, Zhao D, Zhang S, Du T, et al. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. Biomaterials. 2010;31(6):1180–90. doi: 10.1016/j.biomaterials.2009.10.049. – DOI – PubMed
    1. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kappaB: its role in health and disease. J Cell Mol Med. 2004;82(7):434–48. – PubMed
    1. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004;6(3):203–8. doi: 10.1016/j.ccr.2004.09.003. – DOI – PubMed
    1. Fukuyama R, Ng KP, Cicek M, Kelleher C, Niculaita R, Casey G, et al. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells. Mol Carcinog. 2007;46(5):402–13. doi: 10.1002/mc.20288. – DOI – PubMed
    1. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, et al. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery. 2001;130(2):363–9. doi: 10.1067/msy.2001.116672. – DOI – PubMed
    1. Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M, et al. Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 2004;24(2b):675–81. – PubMed
    1. Ban JO, Yuk DY, Woo KS, Kim TM, Lee US, Jeong HS, et al. Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells. J Pharmacol Sci. 2007;104(4):374–83. doi: 10.1254/jphs.FP0070789. – DOI – PubMed
    1. Sutnar A, Pesta M, Liska V, Treska V, Skalicky T, Kormunda S, et al. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases. Tumour Biol J. 2007;28(5):247–52. doi: 10.1159/000110897. – DOI – PubMed
    1. Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Hum Pathol. 2007;38(11):1603–10. doi: 10.1016/j.humpath.2007.03.018. – DOI – PubMed
    1. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2001;1(1):11–21. doi: 10.1038/35094017. – DOI – PubMed
    1. Wang CY, Cusack JC, Jr, Liu R, Baldwin AS., Jr Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 1999;5(4):412–7. doi: 10.1038/7410. – DOI – PubMed
    1. Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Canc Epidemiol Biomarkers Prev. 2008;17(6):1411–7. doi: 10.1158/1055-9965.EPI-07-2693. – DOI – PMC – PubMed
    1. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected] J Biol Chem. 1995;270(42):24995–5000. doi: 10.1074/jbc.270.42.24995. – DOI – PubMed
    1. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene. 1999;18(44):6013–20. doi: 10.1038/sj.onc.1202980. – DOI – PubMed
    1. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20(52):7597–609. doi: 10.1038/sj.onc.1204997. – DOI – PubMed
    1. Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P, Goel A. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-kappaB and Src protein kinase signaling pathways. PLoS One. 2013;8(2) doi: 10.1371/journal.pone.0057218. – DOI – PMC – PubMed
    1. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Canc Res. 2005;11(20):7490–8. doi: 10.1158/1078-0432.CCR-05-1192. – DOI – PubMed
    1. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Canc Res. 2007;13(11):3423–30. doi: 10.1158/1078-0432.CCR-06-3072. – DOI – PubMed
    1. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007;67(8):3853–61. doi: 10.1158/0008-5472.CAN-06-4257. – DOI – PubMed
    1. Shakibaei M, Buhrmann C, Kraehe P, Shayan P, Lueders C, Goel A. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures. PLoS One. 2014;9(1) doi: 10.1371/journal.pone.0085397. – DOI – PMC – PubMed
    1. Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One. 2014;9(9) doi: 10.1371/journal.pone.0107514. – DOI – PMC – PubMed
    1. Chen L, Li WF, Wang HX, Zhao HN, Tang JJ, Wu CJ, et al. Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells. World J Gastroenterol. 2013;19(40):6814–24. doi: 10.3748/wjg.v19.i40.6814. – DOI – PMC – PubMed
    1. Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, et al. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis. 2015;36(3):355–67. doi: 10.1093/carcin/bgv006. – DOI – PMC – PubMed
    1. Rana C, Piplani H, Vaish V, Nehru B, Sanyal SN. Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer. Mol Cell Biochem. 2015;402(1–2):225–41. doi: 10.1007/s11010-015-2330-5. – DOI – PubMed
    1. Zheng A, Li H, Wang X, Feng Z, Xu J, Cao K, et al. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction. Curr Cancer Drug Targets. 2014;14(2):156–66. doi: 10.2174/1568009613666131126115444. – DOI – PubMed
    1. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995–2025. doi: 10.1002/cncr.20162. – DOI – PubMed
    1. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8. doi: 10.1038/nrc1074. – DOI – PubMed
    1. Benson AB., 3rd New approaches to the adjuvant therapy of colon cancer. Oncologist. 2006;11(9):973–80. doi: 10.1634/theoncologist.11-9-973. – DOI – PubMed
    1. Pin AL, Houle F, Huot J. Recent advances in colorectal cancer research: the microenvironment impact. Can Microenvironment. 2011;4(2):127–31. doi: 10.1007/s12307-011-0070-y. – DOI – PMC – PubMed
    1. Ohtsu A. Chemotherapy for metastatic gastric cancer: past, present, and future. J Gastroenterol. 2008;43(4):256–64. doi: 10.1007/s00535-008-2177-6. – DOI – PubMed
    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49. doi: 10.3322/caac.20006. – DOI – PubMed
    1. Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Transl Oncol. 2009;2(4):321–8. doi: 10.1593/tlo.09193. – DOI – PMC – PubMed
    1. Berthiaume F, Moghe PV, Toner M, Yarmush ML. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J. 1996;10(13):1471–84. – PubMed
    1. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982;99(1):31–68. doi: 10.1016/0022-5193(82)90388-5. – DOI – PubMed
    1. Ghosh S, Spagnoli GC, Martin I, Ploegert S, Demougin P, Heberer M, et al. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol. 2005;204(2):522–31. doi: 10.1002/jcp.20320. – DOI – PubMed
    1. Gomez-Lechon MJ, Jover R, Donato T, Ponsoda X, Rodriguez C, Stenzel KG, et al. Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. J Cell Physiol. 1998;177(4):553–62. doi: 10.1002/(SICI)1097-4652(199812)177:4<553::AID-JCP6>3.0.CO;2-F. – DOI – PubMed
    1. Stuelten CH, Mertins SD, Busch JI, Gowens M, Scudiero DA, Burkett MW, et al. Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem Cells. 2010;28(4):649–60. doi: 10.1002/stem.324. – DOI – PMC – PubMed
    1. Sun AM, O’Shea GM, Goosen MF. Injectable microencapsulated islet cells as a bioartificial pancreas. Appl Biochem Biotechnol. 1984;10:87–99. doi: 10.1007/BF02783739. – DOI – PubMed
    1. Shakibaei M, De Souza P, Merker HJ. Integrin expression and collagen type II implicated in maintenance of chondrocyte shape in monolayer culture: an immunomorphological study. Cell Biol Int. 1997;21(2):115–25. doi: 10.1006/cbir.1996.0118. – DOI – PubMed
    1. Wyatt MD, Wilson DM., 3rd Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci. 2009;66(5):788–99. doi: 10.1007/s00018-008-8557-5. – DOI – PMC – PubMed
    1. Li L, Ahmed B, Mehta K, Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther. 2007;6(4):1276–82. doi: 10.1158/1535-7163.MCT-06-0556. – DOI – PubMed
    1. Anitha A, Deepa N, Chennazhi KP, Lakshmanan VK, Jayakumar R. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. Biochim Biophys Acta. 2014;1840(9):2730–43. doi: 10.1016/j.bbagen.2014.06.004. – DOI – PubMed
    1. Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, et al. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharm Res. 2011;28(4):827–38. doi: 10.1007/s11095-010-0336-y. – DOI – PMC – PubMed
    1. Nautiyal J, Kanwar SS, Yu Y, Majumdar AP. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. J Mol Signal. 2011;6:7. doi: 10.1186/1750-2187-6-7. – DOI – PMC – PubMed
    1. Yu LL, Yu HG, Yu JP, Luo HS, Xu XM, Li JH. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol. 2004;10(22):3255–60. doi: 10.3748/wjg.v10.i22.3255. – DOI – PMC – PubMed
    1. Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, et al. Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. J Clin Med Oncol. 2007;25(25):3930–5. doi: 10.1200/JCO.2007.11.5022. – DOI – PubMed
    1. Cascinu S, Berardi R, Salvagni S, Beretta GD, Catalano V, Pucci F, et al. A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation. Br J Cancer. 2008;98(1):71–6. doi: 10.1038/sj.bjc.6604121. – DOI – PMC – PubMed
    1. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Med Oncol. 2005;23(12):2744–53. doi: 10.1200/JCO.2005.07.078. – DOI – PubMed
    1. Ali S, Banerjee S, Schaffert JM, El-Rayes BF, Philip PA, Sarkar FH. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. J Cell Biochem. 2010;110(1):171–81. – PMC – PubMed
    1. Du B, Jiang L, Xia Q, Zhong L. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy. 2006;52(1):23–8. doi: 10.1159/000090238. – DOI – PubMed
    1. Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, et al. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol. 2002;63(9):1709–16. doi: 10.1016/S0006-2952(02)00931-0. – DOI – PubMed
    1. Canil CM, Tannock IF. Is there a role for chemotherapy in prostate cancer? Br J Cancer. 2004;91(6):1005–11. – PMC – PubMed

Request More Information

We'll never share your email with anyone else.
We'll never share your email with anyone else.
We'll never share your company with anyone else.
We'll never share your country with anyone else.
We'll never share your contactNumber with anyone else.
Request

We are always supporting our network of practitioners

Subscribe to our premium service for people like you who are passionate for science and want to know more about nature and its phenomena. Get detailed reports, methods and many more.

Register Sign In

Increase your business growth potential with our patented extracts

Let’s collaborate to refine your ideas or built from scratch

Fix a meeting

Talk to us

Arjuna Natural

Arjuna Natural is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for more than two decades. Established in 1989, the company has grown...Read More

Get all the Updates about us!

For sales enquiries please email us at
sales@arjunanatural.com